Cardiex Ltd
ASX:CDX
Cardiex Ltd
ASX:CDX
Price:
0.054 AUD
1.89%
Market Closed
Updated:
May 5, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
-2.2
Current
-5.1
Median
12.6
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=-2.2
Enterprise Value
/
10.2m
EBITDA
-4.7m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| AU |
|
Cardiex Ltd
ASX:CDX
|
10.5m AUD | -2.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.6B USD | 19.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.3B USD | 55.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.1B USD | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.6B USD | 13.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.8B USD | 30.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 18.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 18.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.3B USD | 26.4 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.8B USD | 59.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 28.3 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
-3.9
3-Years Forward
EV/EBITDA
0.4
You don't have any saved screeners yet
